Patents by Inventor Vijai Joseph

Vijai Joseph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137850
    Abstract: The present invention provides various compositions and methods useful for the diagnosis and treatment of cancer, particularly in subjects having certain mutations in the ERCC3 gene, such as the R109X mutation. In some embodiments such methods involve administration of a class of DNA alkylating agents known as Illudins to the subject.
    Type: Application
    Filed: March 15, 2018
    Publication date: May 13, 2021
    Inventors: Vijai JOSEPH, Kenneth OFFIT, Sabine TOPKA
  • Publication number: 20190247146
    Abstract: The invention relates to a handpiece for simultaneously irrigating and suctioning during an endodontic procedure, the handpiece comprising a handle portion comprising a first fluid line and a second fluid line passing into a head portion comprising an outlet for the first fluid line and an inlet for the second fluid line. The invention also relates to a method of performing a dental procedure such as a root canal. The handpiece permits the procedure of irrigating, cleansing and disinfection to be conducted by a single operator such as an endodontist, a dentist or even a dental student.
    Type: Application
    Filed: February 12, 2018
    Publication date: August 15, 2019
    Inventors: Saju Joseph George, George Vijay Joseph, Sanjay Jacob George
  • Publication number: 20160251722
    Abstract: The present invention relates to novel SNP biomarkers and to panels of biomarkers that may be used in assessing the risk that a patient carrying a BRCA2 mutation will develop breast cancer. It is based, at least in part, on the identification of a SNP located at 6p24 in the human genome which is associated with breast cancer risk in subjects carrying the BRCA2 mutation but not in the general population. In specific non-limiting embodiments, a SNP from the 6p24 region may be used alone or together with one or more breast cancer risk biomarker to evaluate the likelihood that a subject will develop breast cancer.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 1, 2016
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: KENNETH OFFIT, Mia M. Gaudet, Karoline B. Kuchenbaecker, Vijai Joseph, Robert J. Klein, Antonis C. Antoniou